MedTrace Logo

TMS for Complex Regional Pain Syndrome

NCT03137472 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-05-13

No results posted yet for this study

Summary

The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.

Conditions

  • Complex Regional Pain Syndromes

Interventions

DEVICE

Transcranial Magnetic Stimulation (TMS)

The Magventure TMS stimulator will be used to perform intermittent theta burst followed by high frequency Transcranial Magnetic Stimulation (TMS).

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Redlich Pain Endowment

    collaborator UNKNOWN

  • Rocky Mountain Foundation

    collaborator UNKNOWN

  • The Feldman Family Foundation Pain Research Fund

    collaborator UNKNOWN

  • Stanford University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2026-06-29
Completion
2026-06-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03137472 on ClinicalTrials.gov